Page last updated: 2024-08-24

fluorodopa f 18 and Neuroendocrine Tumors

fluorodopa f 18 has been researched along with Neuroendocrine Tumors in 50 studies

Research

Studies (50)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	10 (20.00)	29.6817
2010's	32 (64.00)	24.3611
2020's	8 (16.00)	2.80

Authors

Authors	Studies
Brixi, H; Cadiot, G; Deguelte, S; Jallerat, P; Morland, D; Papathanassiou, D	1
Cadiot, G; Deguelte, S; Jallet, L; Morland, D; Papathanassiou, D	1
Brixi, H; Cadiot, G; Deguelte, S; Lelièvre, M; Morland, D; Perrier, M; Triumbari, EKA	1
Barlier, A; Brue, T; Castinetti, F; Cuny, T; D'Anella, P; Jullien, M; Reichert, T; Taieb, D	1
Barachini, O; Bernt, R; Hergan, K; Mirzaei, S; Pirich, C; Zandieh, S	1
de Mestier, L; Deleval, N; Dieudonné, A; Hentic, O; Lebtahi, R; Pesque, L; Ruszniewski, P; Viry, F	1
Ansquer, C; Carlier, T; Faivre-Chauvet, A; Fleury, V; Frampas, E; Guyetant, S; Kraeber-Bodéré, F; Le Bras, M; Leux, C; Maucherat, B; Rauscher, A; Régenet, N; Scotet-Cérato, E; Senellart, H; Touchefeu, Y	1
Brouwers, AH; de Groot, DJA; Noordzij, W; Veenstra, EB; Walenkamp, AME	1
Cuccurullo, V; Di Stasio, GD; Mansi, L; Prisco, MR	1
Ambrosini, V; Balogova, S; Beheshti, M; Bozkurt, MF; Chiti, A; Decristoforo, C; Delgado-Bolton, R; Fanti, S; Giammarile, F; Kjaer, A; Kunikowska, J; Oyen, WJG; Rubello, D; Sundin, A; Virgolini, I	1
Berends, AMA; Bolt, JW; Brouwers, AH; de Krijger, RR; Kats-Ugurlu, G; Kerstens, MN; Korpershoek, E; Links, TP; Noordzij, W; van der Horst-Schrivers, ANA; van Etten, B; Walenkamp, AME	1
Chantalat, E; Deslandres, M; Gornes, H; Perallon, R; Rimailho, J; Vaysse, C	1
Cuccurullo, V; Di Stasio, GD; Mansi, L	1
Ansquer, C; Bera, G; Bergeret, S; Chanson, P; Charbit, J; Lussey-Lepoutre, C	1
Balogova, S; Huchet, V; Kerrou, K; Michaud, L; Montravers, F; Nataf, V; Talbot, JN	1
Addeo, P; Averous, G; Bachellier, P; Imperiale, A; Namer, IJ	1
Bachellier, P; Detour, J; Duclos, B; Gabriel, S; Goichot, B; Imperiale, A; Kurtz, JE; Namer, IJ; Rust, E; Taïeb, D	1
Schillaci, O	1
Forsback, S; Kauhanen, S; Kemppainen, J; Minn, H; Seppänen, M	1
Santhanam, P; Taïeb, D	1
de Vries, EG; Dierckx, RA; Glaudemans, AW; Noordzij, W; Slart, RH; Tio, RA; van Beek, AP; van der Horst-Schrivers, AN; van Ginkel, B; Walenkamp, AM	1
Brouwers, AH; Dierckx, RA; DiMagno, SG; Elsinga, PH; Kema, IP; Kuik, WJ; Neumann, KD; Zijlma, R	1
Ambrosini, V; Castellucci, P; Fanti, S; Morigi, JJ; Nanni, C	1
Bachellier, P; Gangi, A; Garnon, J; Imperiale, A; Namer, IJ	1
Glaudemans, AW; Slart, RH; Stormezand, GN	1
Kumar, A; Kumar, R; Shamim, SA	1
Imperiale, A; Pacak, K; Taïeb, D	1
Bachellier, P; Caudrelier, J; Cazzato, RL; Gangi, A; Garnon, J; Imperiale, A; Koch, G; Namer, IJ; Ramamurthy, N; Rao, P; Tsoumakidou, G	1
Goichot, B; Heimburger, C; Helali, M; Imperiale, A; Rohr, S	1
Ito, T; Jensen, RT	1
Capriati, V; Dimiccoli, V; Mandracchia, D; Maqoud, F; Mele, A; Scilimati, A; Tolomeo, A; Trapani, A; Trapani, G; Tricarico, D; Vitale, P	1
Arbizu, J; Dominguez-Prado, I; Garrastachu, P; Richter, JA; Rodriguez-Fraile, M; Rotellar, F; Sangro, B	1
Auernhammer, CJ; Bartenstein, P; Göke, B; Haug, A; Pöpperl, G; Schmidt, G; Tiling, R; Wängler, B	1
Kauhanen, S; Minn, H; Nuutila, P; Seppänen, M	1
Gabriel, M; Henninger, B; Kendler, D; Knoflach, M; Kroiss, A; Putzer, D; Virgolini, IJ; Vonguggenberg, E; Warwitz, B	1
Bauerfeind, P; Clavien, PA; Hany, T; Muller, MK; Schiesser, M; Veit-Haibach, P; Weber, M	1
Clavien, PA; Hany, TF; Hesselmann, R; Schaefer, NG; Schiesser, M; Soyka, J; Strobel, K; Veit-Haibach, P	1
Al-Nahhas, A; Bellan, E; Chondrogiannis, S; Ferretti, A; Grassetto, G; Marzola, MC; Massaro, A; Mazza, A; Rampin, L; Rubello, D	1
Gesuwan, K; Herscovitch, P; Kebebew, E; Kitano, M; Linehan, WM; Millo, C; Nilubol, N; Weisbrod, AB	1
Altrinetti, V; Chiti, A; Cistaro, A; Fanti, S; Garaventa, A; Lopci, E; Nanni, C; Pession, A; Piccardo, A; Villavecchia, G	1
Chowdhury, FU; Gross, MD; Marzola, MC; Rubello, D; Scarsbrook, AF; Waterfield, RT; Wong, KK	1
Boulanger, C; Imperiale, A; Ollier, JC; Roedlich, MN; Rust, E; Schneegans, O	1
Gallowitsch, HJ; Malle, P; Sorschag, M	1
Angelberger, P; Becherer, A; Dudczak, R; Karanikas, G; Kletter, K; Kurtaran, A; Raderer, M; Szabó, M; Wunderbaldinger, P	1
Fanti, S; Nanni, C; Rubello, D	1
Al-Nahhas, A; Ambrosini, V; Campana, D; Castellucci, P; Fanti, S; Farsad, M; Franchi, R; Montini, G; Nanni, C; Rubello, D; Tomassetti, P	1
Chen, W; Seibyl, JP; Silverman, DH	1
Brouwers, AH; Chirakal, R; Gulenchyn, KY; Jager, PL; Koopmans, KP; Marriott, CJ	1
Al-Nahhas, A; Ambrosini, V; Fanti, S; Nanni, C; Rubello, D	1
Ambrosini, V; Campana, D; Castellucci, P; Fanti, S; Franchi, R; Montini, G; Nanni, C; Rizzello, A; Rubello, D; Tomassetti, P	1

Reviews

13 review(s) available for fluorodopa f 18 and Neuroendocrine Tumors

Article	Year
Nuclear Medicine in Patients with NET: Radiolabeled Somatostatin Analogues and their Brothers. Current radiopharmaceuticals, 2017, Volume: 10, Issue:2 Topics: Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Nuclear Medicine; Octreotide; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Somatostatin	2017
Physiopathological Premises to Nuclear Medicine Imaging of Pancreatic Neuroendocrine Tumours. Current radiopharmaceuticals, 2019, Volume: 12, Issue:2 Topics: Animals; Dihydroxyphenylalanine; Dimerization; Edetic Acid; Fluorodeoxyglucose F18; Glucagon-Like Peptide-1 Receptor; Humans; Indium Radioisotopes; Insulinoma; Ligands; Mice; Neuroendocrine Tumors; Nuclear Medicine; Octreotide; Pancreatic Neoplasms; Pentetic Acid; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin	2019
Novel PET tracers: added value for endocrine disorders. Endocrine, 2019, Volume: 64, Issue:1 Topics: Dihydroxyphenylalanine; Endocrine System Diseases; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals	2019
18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type. European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:6 Topics: 3-Iodobenzylguanidine; Bronchial Neoplasms; Carcinoma, Merkel Cell; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Recurrence; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon	2013
18F-fluorodihydroxyphenylalanine in the diagnosis of neuroendocrine tumors. PET clinics, 2014, Volume: 9, Issue:1 Topics: Adrenal Gland Neoplasms; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Humans; Intestinal Neoplasms; Neuroendocrine Tumors; Pancreatic Neoplasms; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Thyroid Neoplasms	2014
Role of (18) F-FDOPA PET/CT imaging in endocrinology. Clinical endocrinology, 2014, Volume: 81, Issue:6 Topics: Adrenal Gland Neoplasms; Carbidopa; Carcinoid Tumor; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Dopamine Agents; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neuroendocrine Tumors; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed	2014
Current status of PET imaging of neuroendocrine tumours ([18F]FDOPA, [68Ga]tracers, [11C]/[18F]-HTP). The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2015, Volume: 59, Issue:1 Topics: 5-Hydroxytryptophan; Carbon Radioisotopes; Dihydroxyphenylalanine; Gallium Radioisotopes; Humans; Image Enhancement; Molecular Imaging; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals	2015
PET/Computed Tomography in Neuroendocrine Tumor: Value to Patient Management and Survival Outcomes. PET clinics, 2015, Volume: 10, Issue:3 Topics: Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gastrointestinal Neoplasms; Humans; Multimodal Imaging; Neuroendocrine Tumors; Pancreatic Neoplasms; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy; Thyroid Neoplasms; Tomography, X-Ray Computed	2015
Molecular imaging in neuroendocrine tumors: recent advances, controversies, unresolved issues, and roles in management. Current opinion in endocrinology, diabetes, and obesity, 2017, Volume: 24, Issue:1 Topics: Dihydroxyphenylalanine; Female; Gallium Radioisotopes; Glucagon-Like Peptide 1; Humans; Molecular Imaging; Neuroendocrine Tumors; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Receptors, Somatostatin; Sensitivity and Specificity; Tomography, X-Ray Computed	2017
Contemporary nuclear medicine imaging of neuroendocrine tumours. Clinical radiology, 2012, Volume: 67, Issue:11 Topics: Chromaffin System; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon	2012
Nuclear medicine in NET. Wiener medizinische Wochenschrift (1946), 2012, Volume: 162, Issue:19-20 Topics: Biomarkers, Tumor; Cell Proliferation; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Multimodal Imaging; Neoplasm Staging; Neuroendocrine Tumors; Positron-Emission Tomography; Prognosis; Radionuclide Imaging; Receptors, Peptide; Receptors, Somatostatin; Tomography, X-Ray Computed	2012
3,4-dihydroxy-6-[18f]-fluoro-L-phenylalanine positron emission tomography in patients with central motor disorders and in evaluation of brain and other tumors. Seminars in nuclear medicine, 2007, Volume: 37, Issue:6 Topics: Adrenal Gland Neoplasms; Amino Acids; Brain Neoplasms; Caudate Nucleus; Dihydroxyphenylalanine; Fluorine Radioisotopes; Glioma; Humans; Movement Disorders; Neuroendocrine Tumors; Parkinsonian Disorders; Positron-Emission Tomography; Putamen; Radiopharmaceuticals	2007
6-L-18F-fluorodihydroxyphenylalanine PET in neuroendocrine tumors: basic aspects and emerging clinical applications. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2008, Volume: 49, Issue:4 Topics: Adenoma, Islet Cell; Dihydroxyphenylalanine; Humans; Hyperinsulinism; Neuroendocrine Tumors; Pancreatic Neoplasms; Pheochromocytoma; Positron-Emission Tomography; Thyroid Neoplasms	2008

Trials

3 trial(s) available for fluorodopa f 18 and Neuroendocrine Tumors

Article	Year
18F-DOPA PET/CT in neuroblastoma: comparison of conventional imaging with CT/MR. Clinical nuclear medicine, 2012, Volume: 37, Issue:4 Topics: Child; Dihydroxyphenylalanine; Female; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neuroblastoma; Neuroendocrine Tumors; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed	2012
Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2004, Volume: 45, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Dihydroxyphenylalanine; Female; Humans; Indium Radioisotopes; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed	2004
Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours. Nuclear medicine communications, 2007, Volume: 28, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Digestive System Neoplasms; Dihydroxyphenylalanine; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neuroendocrine Tumors; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Somatostatin; Tomography, X-Ray Computed; Ultrasonography	2007

Other Studies

34 other study(ies) available for fluorodopa f 18 and Neuroendocrine Tumors

Article	Year
Performances of 18F-FDOPA PET/CT in the Preoperative Evaluation of the Peritoneal Cancer Index in Small Intestine Neuroendocrine Tumors. Clinical nuclear medicine, 2022, Apr-01, Volume: 47, Issue:4 Topics: Dihydroxyphenylalanine; Humans; Intestine, Small; Neuroendocrine Tumors; Positron Emission Tomography Computed Tomography; Retrospective Studies	2022
Orbital Metastasis: A Rare but Typical Location of Small Intestine Neuroendocrine Tumor on 18F-FDOPA PET/CT. Clinical nuclear medicine, 2022, Aug-01, Volume: 47, Issue:8 Topics: Dihydroxyphenylalanine; Humans; Intestinal Neoplasms; Intestine, Small; Neuroendocrine Tumors; Positron Emission Tomography Computed Tomography	2022
Bone metastases in midgut neuroendocrine tumors: imaging characteristics, distribution, and risk factors. Endocrine, 2022, Volume: 78, Issue:2 Topics: Bone Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Risk Factors	2022
Comparison of 68Ga-Dotatate PET/CT and 18F-FDOPA PET/CT for the diagnosis of pancreatic neuroendocrine tumors in a MEN1 patient. Annales d'endocrinologie, 2020, Volume: 81, Issue:1 Topics: Dihydroxyphenylalanine; Female; Humans; Middle Aged; Multiple Endocrine Neoplasia Type 1; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography	2020
The impact of 18F-FDOPA-PET/MRI image fusion in detecting liver metastasis in patients with neuroendocrine tumors of the gastrointestinal tract. BMC medical imaging, 2020, 02-24, Volume: 20, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Diffusion Tensor Imaging; Dihydroxyphenylalanine; Female; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neuroendocrine Tumors; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Sensitivity and Specificity; Whole Body Imaging; Young Adult	2020
Prognostic impact of bone metastases detected by European radiology, 2021, Volume: 31, Issue:6 Topics: Aged; Dihydroxyphenylalanine; Humans; Neuroendocrine Tumors; Positron-Emission Tomography; Prognosis	2021
Head-to-Head Comparison of 18F-DOPA PET/CT and 68Ga-DOTANOC PET/CT in Patients With Midgut Neuroendocrine Tumors. Clinical nuclear medicine, 2021, Mar-01, Volume: 46, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Dihydroxyphenylalanine; Female; Humans; Intestinal Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies; Stomach Neoplasms	2021
Comparison of 18F-DOPA Versus 68Ga-DOTATOC as Preferred PET Imaging Tracer in Well-Differentiated Neuroendocrine Neoplasms. Clinical nuclear medicine, 2021, Mar-01, Volume: 46, Issue:3 Topics: Adult; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity	2021
Guideline for PET/CT imaging of neuroendocrine neoplasms with European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:9 Topics: Dihydroxyphenylalanine; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Image Interpretation, Computer-Assisted; Neuroendocrine Tumors; Peptides; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Quality Control; Receptors, Somatostatin; Tissue Distribution	2017
False-positive findings on 6-[18F]fluor-l-3,4-dihydroxyphenylalanine PET ( European journal of endocrinology, 2018, Volume: 179, Issue:2 Topics: Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; False Positive Reactions; Female; Humans; Immunohistochemistry; Intestinal Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radionuclide Imaging; Retrospective Studies; Stomach Neoplasms; Tissue Distribution	2018
Discovery of a neuroendocrine tumor of the caecum by mammary metastasis using 18F-DOPA-PET. The journal of obstetrics and gynaecology research, 2018, Volume: 44, Issue:12 Topics: Adult; Breast Neoplasms; Cecal Neoplasms; Dihydroxyphenylalanine; Female; Humans; Neoplasm Metastasis; Neuroendocrine Tumors; Positron-Emission Tomography	2018
Solid pseudopapillary pancreatic tumor mimicking a neuroendocrine neoplasm on ¹⁸F-FDOPA PET/CT. The Journal of clinical endocrinology and metabolism, 2013, Volume: 98, Issue:7 Topics: Adult; Carbidopa; Diagnosis, Differential; Dihydroxyphenylalanine; Dopamine Agents; Fluorine Radioisotopes; Humans; Male; Multimodal Imaging; Neuroendocrine Tumors; Pancreas; Pancreatic Neoplasms; Positron-Emission Tomography; Premedication; Radiopharmaceuticals; Tomography, X-Ray Computed	2013
18F-fluorodihydroxyphenylalanine PET/CT in patients with neuroendocrine tumors of unknown origin: relation to tumor origin and differentiation. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:3 Topics: Adult; Aged; Cohort Studies; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Positron-Emission Tomography; Receptors, Somatostatin; Retrospective Studies; Tomography, X-Ray Computed	2014
18F-DOPA and other radiopharmaceuticals for imaging unknown primary neuroendocrine tumors. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:3 Topics: Dihydroxyphenylalanine; Female; Humans; Male; Multimodal Imaging; Neuroendocrine Tumors; Positron-Emission Tomography; Tomography, X-Ray Computed	2014
Myocardial metastases on 6-[18F] fluoro-L-DOPA PET/CT: a retrospective analysis of 116 serotonin producing neuroendocrine tumour patients. PloS one, 2014, Volume: 9, Issue:11 Topics: Carcinoid Heart Disease; Dihydroxyphenylalanine; Female; Heart Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Myocardium; Neuroendocrine Tumors; Positron-Emission Tomography; Retrospective Studies; Serotonin; Tomography, X-Ray Computed; Ultrasonography	2014
In vivo biodistribution of no-carrier-added 6-18F-fluoro-3,4-dihydroxy-L-phenylalanine (18F-DOPA), produced by a new nucleophilic substitution approach, compared with carrier-added 18F-DOPA, prepared by conventional electrophilic substitution. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:1 Topics: Animals; Cell Line, Tumor; Dihydroxyphenylalanine; Drug Stability; Humans; Male; Mice; Neuroendocrine Tumors; Positron-Emission Tomography; Radiochemistry; Tissue Distribution	2015
Simultaneous (18)F-FDOPA PET/CT-guided biopsy and radiofrequency ablation of recurrent neuroendocrine hepatic metastasis: further step toward a theranostic approach. Clinical nuclear medicine, 2015, Volume: 40, Issue:6 Topics: Ablation Techniques; Dihydroxyphenylalanine; Humans; Ileal Neoplasms; Image-Guided Biopsy; Liver; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neuroendocrine Tumors; Positron-Emission Tomography; Radiofrequency Therapy; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
(18)F-FDOPA accumulation in traumatic rib fractures: a potential pitfall. Clinical nuclear medicine, 2015, Volume: 40, Issue:6 Topics: Diagnostic Errors; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Multimodal Imaging; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals; Rib Fractures; Tomography, X-Ray Computed	2015
(18)F-DOPA: the versatile radiopharmaceutical. European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:6 Topics: Biological Transport; Dihydroxyphenylalanine; Humans; Neuroendocrine Tumors; Nuclear Medicine; Radiopharmaceuticals	2016
18F-FDOPA PET/CT-Guided Radiofrequency Ablation of Liver Metastases from Neuroendocrine Tumours: Technical Note on a Preliminary Experience. Cardiovascular and interventional radiology, 2016, Volume: 39, Issue:9 Topics: Adult; Catheter Ablation; Dihydroxyphenylalanine; Female; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiography, Interventional; Treatment Outcome	2016
Small Bowel Carcinoid: The "Dancing Bowel Sign" on 18F-FDOPA PET/CT. Clinical nuclear medicine, 2016, Volume: 41, Issue:12 Topics: Adult; Carcinoid Tumor; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Intestinal Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Positron Emission Tomography Computed Tomography	2016
A novel injectable formulation of 6-fluoro-l-DOPA imaging agent for diagnosis of neuroendocrine tumors and Parkinson's disease. International journal of pharmaceutics, 2017, Mar-15, Volume: 519, Issue:1-2 Topics: Animals; beta-Cyclodextrins; Cell Line, Tumor; Chemistry, Pharmaceutical; Cysteine; Dihydroxyphenylalanine; Humans; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Muscle Fibers, Skeletal; Neuroblastoma; Neuroendocrine Tumors; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Wistar	2017
Whole body 18fluoro-L-dopa PET-CT: a useful tool for location and surgical guidance in primary carcinoid tumours. European journal of nuclear medicine and molecular imaging, 2008, Volume: 35, Issue:8 Topics: Adolescent; Dihydroxyphenylalanine; Female; Humans; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Surgery, Computer-Assisted; Tomography, X-Ray Computed	2008
Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumours. European journal of nuclear medicine and molecular imaging, 2009, Volume: 36, Issue:5 Topics: Adult; Aged; Dihydroxyphenylalanine; Female; Gallium Radioisotopes; Humans; Male; Middle Aged; Neoplasm Metastasis; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Sensitivity and Specificity; Serotonin	2009
18F-FDOPA: a multiple-target molecule. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2009, Volume: 50, Issue:12 Topics: Adult; Biological Transport; Dihydroxyphenylalanine; Humans; Hyperinsulinism; Infant, Newborn; Neuroendocrine Cells; Neuroendocrine Tumors; Positron-Emission Tomography; Tomography, X-Ray Computed	2009
Comparison of (68)Ga-DOTA-Tyr(3)-octreotide and (18)F-fluoro-L-dihydroxyphenylalanine positron emission tomography in neuroendocrine tumor patients. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2010, Volume: 54, Issue:1 Topics: Adolescent; Adult; Aged; Dihydroxyphenylalanine; Female; Gallium Radioisotopes; Humans; Male; Middle Aged; Neoplasm Staging; Neuroendocrine Tumors; Octreotide; Positron-Emission Tomography; Young Adult	2010
Value of combined 6-[18F]fluorodihydroxyphenylalanine PET/CT for imaging of neuroendocrine tumours. The British journal of surgery, 2010, Volume: 97, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Spiral Computed	2010
Clinical value of a combined multi-phase contrast enhanced DOPA-PET/CT in neuroendocrine tumours with emphasis on the diagnostic CT component. European radiology, 2011, Volume: 21, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Dihydroxyphenylalanine; Female; Humans; Iohexol; Male; Middle Aged; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Young Adult	2011
18F-DOPA PET/CT biodistribution consideration in 107 consecutive patients with neuroendocrine tumours. Nuclear medicine communications, 2012, Volume: 33, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Dihydroxyphenylalanine; Female; Humans; Image Enhancement; Male; Middle Aged; Multimodal Imaging; Neuroendocrine Tumors; Positron-Emission Tomography; Tissue Distribution; Tomography, X-Ray Computed; Young Adult	2012
Clinical utility of functional imaging with ¹⁸F-FDOPA in Von Hippel-Lindau syndrome. The Journal of clinical endocrinology and metabolism, 2012, Volume: 97, Issue:4 Topics: Adult; Central Nervous System Neoplasms; Cohort Studies; Contrast Media; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Kidney Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Prospective Studies; von Hippel-Lindau Disease	2012
Terminal ileum neuroendocrine incidentaloma in a patient with sporadic medullary thyroid carcinoma: findings from 18F-FDOPA PET/CT investigation. Clinical nuclear medicine, 2012, Volume: 37, Issue:8 Topics: Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Humans; Ileal Neoplasms; Incidental Findings; Middle Aged; Multimodal Imaging; Neuroendocrine Tumors; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging	2012
18F-DOPA PET/CT and neuroendocrine tumours. European journal of nuclear medicine and molecular imaging, 2006, Volume: 33, Issue:5 Topics: Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed	2006
68Ga-DOTA-peptides versus 18F-DOPA PET for the assessment of NET patients. Nuclear medicine communications, 2008, Volume: 29, Issue:5 Topics: Dihydroxyphenylalanine; Humans; Neuroendocrine Tumors; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity	2008
Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours. European journal of nuclear medicine and molecular imaging, 2008, Volume: 35, Issue:8 Topics: Aged; Aged, 80 and over; Dihydroxyphenylalanine; Female; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity	2008

chemdatabank.com